Vicarious Surgical Inc.

NYSE: RBOT · Real-Time Price · USD
6.92
-0.54 (-7.24%)
At close: Aug 15, 2025, 12:42 PM

Vicarious Surgical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 2.09M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
413K 369K 1.04M 507K 524K 521K 525K 447K 641K 637K 595K 539K 186K 185K n/a 84K n/a n/a
Gross Profit
-413K -369K 1.04M -507K -524K -521K -525K -447K -641K -637K -595K -539K -186K -185K -126K -84K n/a n/a
Operating Income
-13.52M -15.75M -14.98M -17.75M -17.71M -16.11M -15.54M -21.35M -21.46M -22.32M -20.61M -22.16M -19.13M -18.18M -17.82M -8.56M -6.61M -5.23M
Interest Income
264K 446K 594K 802K 918K 975K 966K 946K 1.04M 1.47M 832K 494K 101K 8K 19K n/a 1K 1K
Pretax Income
-13.21M -15.39M -13.93M -17.09M -15.21M -17M -13.11M -15.7M -15.33M -26.92M -11.18M -24.74M -1.45M 42.53M 42.14M -45.12M -6.64M -3.18M
Net Income
-13.21M -15.39M -13.93M -17.09M -15.21M -17M -13.11M -15.7M -15.33M -26.92M -11.18M -24.74M -1.45M 42.53M 42.14M -45.12M -6.64M -3.18M
Selling & General & Admin
4.47M 6.33M 6.51M 6.96M 6.79M 6.14M 7.07M 8.31M 8.74M 8.96M 8.73M 10.04M 9.07M 8.33M 8.56M 3.37M 2.6M 1.62M
Research & Development
9.05M 9.41M 8.46M 10.8M 10.92M 9.45M 8.47M 13.04M 12.71M 13.36M 11.88M 12.12M 10.05M 9.85M 9.3M 5.19M 4.01M 3.61M
Other Expenses
n/a n/a n/a n/a n/a 521K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
13.52M 15.75M 14.98M 17.75M 17.71M 16.11M 15.54M 21.35M 21.46M 22.32M 20.61M 22.16M 19.13M 18.18M 17.82M 8.56M 6.61M 5.23M
Interest Expense
n/a n/a n/a n/a n/a n/a 22K 1K 1K 1K 111K 31K 29K 29K 30K 31K 27K 1K
Selling & Marketing Expenses
349K 1.04M 979K 1.21M 1.2M 1.14M 1.2M 1.4M 1.67M 1.96M 1.84M 1.91M 1.31M 1.4M 1.57M 842K 325K 226K
Cost & Expenses
13.52M 15.75M 14.98M 17.75M 17.71M 16.11M 15.54M 21.35M 21.46M 22.32M 20.61M 22.16M 19.13M 18.18M 17.82M 8.56M 6.61M 5.23M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 26K -1.66M
Shares Outstanding (Basic)
5.94M 5.92M 5.91M 5.9M 5.87M 5.35M 5.83M 5.17M 4.23M 4.2M 4.11M 4.06M 4.04M 4.01M 3.97M 3.07M 2.76M 3.95M
Shares Outstanding (Diluted)
5.94M 5.92M 5.91M 5.9M 5.87M 5.37M 5.83M 5.17M 4.23M 4.2M 4.11M 4.06M 4.04M 4.25M 3.97M 3.07M 2.92M 3.95M
EPS (Basic)
-2.23 -2.6 -2.36 -2.9 -2.59 -3.18 -2.25 -3.04 -3.62 -6.3 -2.7 -6 -0.36 10.50 17.67 -14.7 -2.4 -1.8
EPS (Diluted)
-2.23 -2.6 -2.36 -2.9 -2.59 -3.17 -2.25 -3.04 -3.62 -6.3 -2.7 -6 -0.36 9.90 17.67 -14.7 -2.27 -1.8
EBITDA
-13.52M -15.38M -13.38M -16.58M -14.67M -15.59M -12.56M -15.26M -14.69M -26.28M -10.67M -24.17M -1.24M 42.74M 42.3M -45.01M -6.55M -5.19M
EBIT
-13.21M -15.75M -13.93M -17.09M -15.21M -16.11M -13.09M -15.7M -15.33M -26.92M -11.07M -24.71M -1.42M 42.56M 42.17M -45.09M -6.61M -5.23M
Depreciation & Amortization
413K 369K 542K 507K 524K 521K 525K 447K 641K 637K 595K 539K 186K 185K 126K 84K 64K 41K